Inhaled sildenafil as an alternative to oral sildenafil in the treatment of pulmonary arterial hypertension (PAH).

Rashid J, Patel B, Nozik-Grayck E, McMurtry IF, Stenmark KR, Ahsan F. Inhaled sildenafil as an alternative to oral sildenafil in the treatment of pulmonary arterial hypertension (PAH). J Control Release. 2017 03 28; 250:96-106.

View in: PubMed

subject areas

Administration, Inhalation
Administration, Oral
Animals
Drug Carriers
Humans
Hypertension, Pulmonary
Lactic Acid
Macrophages, Alveolar
Male
Microspheres
Muscle, Smooth, Vascular
Particle Size
Phosphodiesterase 5 Inhibitors
Polyethyleneimine
Polyglycolic Acid
Porosity
Pulmonary Artery
Rats, Sprague-Dawley
Sildenafil Citrate
Surface Properties
Vasodilator Agents

authors with profiles

Kurt R Stenmark
Eva S Nozik